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Abstract: To present the visual outcome of
patients with solar retinopathy and evaluate
the effects of treatment on the visual
prognosis.

Department of Ophthalmology, Faculty of
Medicine, F›rat University, Elaz›¤ - Turkey

One hundred and eighty-eight patients with
visual disturbances applied for ophthalmic
examination following the solar eclipse on
August 11, 1999. All patients underwent
routine ophthalmologic examination; those
with fundus changes also underwent fundus
fluorescein angiography, Amsler grid and
computerised perimetry. Among them, nine
patients (11 eyes) were evaluated as having
solar retinopathy with decreased visual acuity
and discernible fundus findings. Mean age was
21.5 (17-34) in this group. Five patients
were given treatment, three were on oral
methyl prednisolon and two were on ginkgo
glycosides. Statistical analysis could not be
performed because of the small number of
patients in the treatment groups.

Introduction
Solar retinopathy is a well-recognised clinical entity of
retinal damage caused by direct or indirect viewing of the
sun. Synonymous terms include foveomacular retinitis,
eclipse retinopathy, solar retinitis, eclipse blindness,
eclipse burn and solar chorioretinal burn (1). While the
majority of cases of solar retinopathy have involved
eclipse viewing, sailors, photographers, religious sungazers, schizophrenics, people under the influence of
hallucinogenic drugs and even sunbathers are at risk of
developing this form of retinopathy (2-4).
The number of reported cases of solar retinopathy
after the solar eclipse of the August, 1999 was extremely
small because of extensive information in the media about
appropriate protection and the presence of cloudy
weather over most parts of Europe (5-8).
Various factors may determine the severity of the
retinal lesions and the loss of visual acuity (VA) in solar
retinopathy. Increased duration of exposure and the

The duration of exposure was 1-30 min. The
mean initial visual acuity was 20/32 (min
20/100, max 20/25). All eyes aside from one
revealed positive Amsler grid tests.
Computerised perimetry showed central
scotoma in four eyes. The mean visual acuity
at final examination (3 months later) was
20/24
(min
20/50,
max
20/20).
Metamorphopsia persisted in five eyes, and
disability at near vision persisted in one eye
after 3 months. Early and late fundoscopic
findings did not correlate with either duration
of exposure or visual acuity.
Reversible or persistant visual abnormalities
may follow a solar retinal burn. Prevention
seems to remain the best treatment.
Corticosteroids may be beneficial in severe
cases.
Key Words: Solar retinopathy, protection,
and treatment.

protection used are the major risk factors for retinopathy
and generally correlate with the severity of retinal lesions
(1,3). However, retinal lesions with very short exposure
to the sun were reported (9). Viewing an eclipse through
binoculars, sunglasses, exposed photographic or
radiographic film or audio CDs is never safe (10).
Commercial solar filters certified as being safe have been
shown to be the only safe method for eclipse observation
(11). An increased risk of retinal damage has been
associated with the use of photosensitising drugs like
tetracycline and psoralen (1). Variability in the degree of
susceptibility to photic damage suggests that host factors
are also important (12).
Most cases of solar retinopathy improve over time
without treatment (13). Despite the lack of a
standardised protocol, corticosteroids and antioxidants
are believed to be beneficial in the treatment of solar
retinopathy (14,15). In this article we present the visual
outcomes in a series of young adult patients who
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developed solar retinopathy following an eclipse of the
sun and try to analyse the effects of treatment with oral
methyl prednisolon and ginkgo glycosides.

Materials and Methods
Ocular histories and examinations were obtained from
188 patients who reported visual disturbances between 2
and 6 days following a solar eclipse on August 11, 1999.
All patients were living in the Elaz›¤ region, where the
total eclipse could be viewed, and all of them reported
their symptoms following the viewing of the eclipse. In
addition to a complete ophthalmologic examination
including VA testing, slit-lamp examination, intraocular
pressure determination and ophthalmoscopy, Amslergrid, visual field testing and fluorescein angiography were
performed in patients who had positive fundus findings
with decreased VA. One hundred and sixty-nine of the
188 patients had either a history of after-image for a few
minutes or displayed ocular surface problems due to
extended ultraviolet exposure; so they were excluded.
Ten patients with decreased VA due to refractive errors,
amblyopia, and lens opacities were also excluded. Retinal
changes along with VA loss were observed in 11 eyes of
the remaining nine patients following the solar eclipse and
diagnosed as solar retinopathy. During exposure, four
patients were absolutely unprotected and five were
protected by inappropriate methods like processed X-ray
film, sooty glasses or ordinary sunglasses. Exposure
intervals were between 1 and 30 min. None of these
patients was predisposed to solar retinopathy because of
any known risk factor like systemic or topical
medications, or ocular and systemic diseases.
After completing the initial tests, three severely
affected patients were given methyl prednisolon (60
mg/day) for 10 days following initial examination. Two
randomly selected patients (cases 3 and 6) were put on
ginkgo glycoside 9.6 mg b.i.d. for 4 weeks. The
remaining patients were followed without medication.
Because of the small number of patients and the lack of
randomised distribution between groups, no statistical
analysis could be performed.

Results
Blurred vision, central scotoma, metamorphopsia,
headache and after-image were the main symptoms of
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patients. The demographic features and clinical findings
at first examination and treatment modalities are
summarised in Table 1. The VA of the patients was
between 20/100 and 20/25 (mean 20/32) at initial
examination. All patients had discernible fundus changes;
most of them being foveal grey-yellow cysts with
surrounding oedema (seven eyes). Figure 1 shows left
foveal lesion in case 2. The other fundus changes were
macular oedema and discoloration without a cyst in two
eyes (cases 4 and 7) and reddish, well-circumscribed
depression again in two eyes (both eyes of case 5). Figure
2 shows right foveal depression with reflecting borders in
case 5. Fluorescein angiographic findings were normal in
all cases except case 4, in which a window defect was
seen. Amsler grid revealed central/paracentral scotoma
and metamorphopsia in all patients except case 7. Four of
these eyes also showed central scotoma in a 10 degree
area with computerised perimetry. Final VA in nine eyes
was better than 20/25. Mean VA of our patients at the
end of 3 months was 20/24 (20/50 - 20/20). The mean
increase in VA of the treated eyes was 1.86 Snellen lines
(2.2 line in corticosteroid group and 1 line in ginkgo
glycoside groups). Mean increase in VA of the no
treatment group was 1.25 lines. At the end of 3 months,
three of the 11 eyes were free from symptoms.
Metamophopsia persisted in seven eyes; one with
disability at near vision. The results of the follow-up
examinations are summarised in Table 2.

Discussion
The extent of retinal damage and associated visual
impairment is reported to be dependent upon the
intensity and duration of solar exposure (3,13). In spite
of the difficulties in stating the correlation of clinical
findings with exposure time and protection in such a small
group, these factors did not seem to be correlated with
retinal lesions and the VA in our patients. It should be
noted that reported periods were estimated and not
measured exactly. None of our patients had appropriate
protection; however, we estimated the total number of
people who viewed the eclipse unprotected in the Elaz›g
region as being quite numerous. This supports the theory
of individual susceptibility (1).
Reported symptoms of solar retinopathy include
decreased VA, metamorphopsia, micropsia, central or
paracentral scotoma, chromatopsia, photophobia, after-
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Table 1.

Table shows the demographics, exposure times, results of the first ophthalmologic examination and medications initiated. (BCVA: Best
corrected visual acuity, MP: methyl prednisolone, GG: gingko glycoside).

Case

Agesex
exp time

BCVA Right-Left

Fundus examination

Fluorescein
angiogram

Other tests

Treatment

1

34/F
10 min

20/20-20/30

Left foveal cyst and perifoveal
granular appearance

Normal

Relative central scotoma with Amsler
grid in left eye

None

2

18/F
30 min

20/40-20/30

Yellow-white, elevated irregular
cyst & greyish halo in both foveae

Normal

Relative central scotoma &
metamorphopsia in both eye
(in visual field Amsler grid)

MP

3

17/F
15 min

20/25-20/20

Yellowish cystic lesion
on right fovea

Normal

A faint scotoma on Amsler
grid in right eye

GG

4

19/F
10 min

20/25-20/20

Greyish discoloration and
oedema in right macula

Right faded
window defect

Metamorphopsia (Amsler grid)/normal
visual field in right eye

None

5

20/F
5 min

20/30-20/60

Bilateral small, reddish,
well circumscribed depression;
prominent in left eye

Normal

Bilateral metamorphopsia and central
scotoma on Amsler grid

MP

6

24/F
1 min

20/20-20/25

Retinal irregularity in both foveae
tiny cyst in left fovea

Normal

A faint scotoma on Amsler
grid in left eye

GG

7

23/F
20 sec

20/25-20/20

Macular oedema and
pigmentary changes in right eye

Normal

No abnormality

None

8

18/M
10 min

20/100-20/20

Juxtafoveal cyst in right eye

Normal

Metamorphopsia and central scotoma on
Amsler grid in right eye

MP

9

21/M
20 min

20/30-20/20

Right foveal cyst, perifoveal
oedema & pigmentation

Normal

Small central scotoma in right
visual field testing

None

Table 2.

Table shows the results of the first (at the end of first month) and second (at the end of the third month) follow-up examinations. (BCVA:
Best corrected visual acuity).

Case

BCVA at 1 month
Right-Left

Fundus examination
1 month

BCVA at 3 months
Right-Left

Fundus examination/visual field
3 months

Persisting symptoms
3 months

1

20/20-20/20

Cystic lesion & mild pigmentary changes

20/20-20/20

Cystic macular lesion/
normal visual field

mild metamorphopsia

2

20/30-20/25

Elevated yellow cysts in both foveae

20/30-20/25

Tiny yellow cyst & pigmentary
changes/right scotoma in
visual field

Central scotomas &
metamorphopsia

3

20/20-20/20

Yellowish cyst in right fovea

20/20-20/20

Yellowish discoloration/
normal visual field

No symptom

4

20/20-20/20

Greyish discoloration
in left fovea

20/20-20/20

Greyish discoloration/
normal visual field

No symptom

5

20/25-20/30

Sharply circumscribed
reddish depression in left fovea

20/25-20/25

Small depression in both
foveae/left central scotoma

Bilateral metamorphopsia

6

20/20-20/20

Yellowish discoloration

20/20-20/20

Yellow dots in left fovea,
normal visual field

Mild disturbance in
Amsler grid (left)

7

20/20-20/20

No oedema-persisting
pigmentary changes in right eye

20/20-20/20

Pigmentary changes/ normal visual field

No symptom

8

20/80-20/20

Juxtafoveal cyst-like lesion in right eye

20/50-20/20

Juxtafoveal cyst in right
eye /persisting scotoma
and metamorphopsia in visual fields

Central scotoma

9

20/25-20/20

Persisting cystic lesion in right eye

20/25-20/20

Disturbed foveal reflex in
right eye due to cyst/tiny
central scotoma

Moderate disability
at near vision
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Figure 1.

Left fundus photograph of case 2 shows elevated yellow
cyst and surrounding greyish halo.

image and headache (1,6,12,16). Most of these
symptoms were also seen in our group. Shortly after
exposure to the sun, the VA was reported to decrease to
a range between 20/40 and 20/100, but may be worse
(12). Visual acuities were decreased in involved eyes
(20/25 - 20/100) of our patients. In their group of 33
eyes, Kawa et al. reported that all of the patients revealed
positive Amsler tests with decreased VA (17). Ten of the
11 eyes in our group had positive Amsler tests. Seven of
our patients had unilateral involvement (five right and
two left eyes). This was possibly due to the tendency of
the patients to squint the non-dominant eye – mostly the
left eye - to reduce their photophobia (1).
The extent of the fundus changes are variable in solar
retinopathy. Michaelides et al. reported an abnormal
macular appearence at presentation in 84% of their
patients (6). This ratio was 47% in the case group of
Verma et al. (3). In our group, all eyes had macular
changes, since abnormal macular appearance was an
inclusion criterion for this study. The typical fundus lesion
is a small yellow spot with a surrounding grey zone in the
foveolar or parafoveolar area within the first few days of
exposure (18). Afterwards, pigmentary changes surround
the yellow spot, which is usually replaced by a depression.
A perifoveal greyish thickening, punctate atrophic
disturbance of RPE or a pseudolamellar macular hole may
persist (12,18,19). Along with this type of lesion which
was seen in seven eyes, two different clinical finding were
determined in our group: macular oedema with
discoloration in two eyes and reddish depression in two
eyes. The correlation between the severity of the fundus
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Figure 2.

Right fundus photograph of case 5 shows reddish
depression with sharp and reflecting borders in right fovea.

lesions and VA is controversial (2,19). The most severe
lesions in our group were seen with moderate VA loss and
excellent visual prognosis (cases 1 and 4). Fluorescein
angiography (FA) is often normal in the early and late
stages of the disease, though may rarely show a small
window defect corresponding to the lamellar hole
(12,18). Atmaca et al. reported normal fluorescein
angiographic findings in all of 86 eyes of their patients
and evaluated it as a non-conclusive test in solar
retinopathy (19). Dhir et al. reported microleaks and
masking of choroidal fluorescein in early FA studies of
severe cases (2). Only one eye in our group showed
window defect, but there was no hole formation in this
eye at the end of the third month.
The final VA was reported as 20/20 to 20/40 in most
patients with solar retinopathy, which was reached within
3-9 months (12). Atmaca et al. reported a more
prominent and earlier improvement in VA in eyes with an
initial VA of 20/100 or better (19). In our group, eight
eyes with 20/30 or better VA reached their final visual
acuities of 20/25 or better at the end of the first month.
Severe cases with VAs less than 20/40 (cases 2, 5 and 8)
were still healing in the third month. Our results seem to
support the theory of early improvement in mild cases
(19). In spite of a generally good prognosis, return of VA
to 20/20 does not always imply complete recovery
because of persistent central scotoma, image distortion
and macular changes which may dramatically reduce
reading performance in some patients (17). Case 9 in this
report displayed such a difficulty in reading even after the
disappearance of his visual field defect. His findings were
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probably due to a small central scotoma. Those minute
scotomas are too small to be detected by standard
perimeters, but may be found with scanning laser
ophthalmoscopy (16).
Despite the controversial treatment of solar
retinopathy, and lack of a standardised protocol,
corticosteroids are believed to be beneficial in the
treatment of solar retinopathy because of their ability to
suppress inflammatory tissue reactions after injury
(13,14,20). We used methyl prednisolone in three of our
patients and, regarding the mean increase in VA, the
outcome of these patients seemed better than the others.
Antioxidants may also ameliorate retinal photic injury
(15). We used the free radical scavenger gingko
glycosides in two patients with mild involvement. Our
results must be evaluated with suspicion since the groups
are very small and the selection of patients for groups
was non-randomised.

The pathogenesis of solar retinopathy is likely to be
dependent on finely balanced components including an
individual’s age, ocular status, degree of exposure and
intrinsic susceptibilities. Appropriate protective measures
while viewing an eclipse and education about the hazards
of direct staring are the mainstays in the prevention of
this disease. This small population of solar retinopathy
patients gave us a positive impression of the beneficial
effects of corticosteroid therapy in visual acuities of
severely involved eyes.
Corresponding author:
Nuray AKYOL
F›rat Medical Center, Department of Ophthalmology
Elaz›¤ - TURKEY
E-mail: NAKYOL@firat.edu.tr

References
1.

Yannuzzi LA, Fisher YL, Slakter J,
Krueger A. Thesis: Solar retinopathy. A
photobiologic and geophysical analysis.
Retina 9: 28-43,1989.

2.

3.

8.

Dhir SP, Gupta A, Jain IS. Eclipse
retinopathy. Br J Ophthalmol 65: 4245, 1981.

Bechmann M, Ehrt O, Thiel MJ, Kristin
N, Ulbig MW, Kampik A. Optical coherence tomography findings in early solar
retinopathy. B J Ophthalmol 84: 547-8,
2000.

9.

Verma L, Sharma N, Tewari HK, Gupta
S. Retinopathy after solar eclipse, 1995.
Natl Med J India 9: 266-7, 1996.

Sadun AC, Sadun AA, Sadun LA. Solar
retinopathy: A biophysical analysis.
Arch Ophthalmol 102: 1510-12, 1984.

10.

Mainster MA. Solar eclipse safety. Ophthalmol 105: 9-10,1998.

11.

Stalmans P, Weckhuysen B, Schoonheydt R, Leys A, Missotten L, Spileers W,
Dralands L. How to protect your eyes
from solar retinopathy. Bull Soc Belge
Ophtalmol 272: 93-100, 1999.

12.

Lee BL, Sternberg P. Solar retinopathy
In: Phototoxicity of the macula. Ophthalmol Clin North America 6: 231237,1993.

13.

Istock TH. Solar retinopathy: a review
of the literature and case report. J Am
Optom Assoc 56: 374-82,1985.

14.

Kerr LM, Little HL. Foveomacular retinitis. Arch Ophthalmol 76: 498504,1996.

4.

Rai N, Thuladar L, Brandt F, Arden GB,
Berninger TA. Solar Retinopathy. A
study from Nepal and from Germany.
Doc Ophthalmol 95: 99-108,1998.

5.

Sutter FKP, Barmettler A, Helbig H.
Sickle form macular whitening in a child
after viewing a solar eclipse. B J Ophthalmol 84: 1433-4, 2000.

6.

7.

Michealides M, Rajendram R, Marshall
J, Keightley S. Eclipse retinopathy. Eye
15: 148-51, 2001.
Wong SC, Eke T, Ziakas NG. Eclipse
burns: A prospective study of solar
retinopathy following the solar eclipse.
Lancet 357: 199-200, 2001.

15.

Kozaki J, Takeuchi M, Takahashi K,
Yamagishi K,Ohkuma H, Uyama M.
Light induced retinal damage in pigmented rabbit 2. Effect of alpha-tocopherol. Nippon Ganka Gakkai Zasshi
98: 948-954,1994.

16.

Ehrt O, Tavcar I, Eckl-Titz G.
Microperimetry and reading saccades in
retinopathia solaris. Follow-up with the
scanning laser ophthalmoscope. Ophthalmologe 96: 325-31, 1999.

17.

Kawa P, Mankowska A, Mackiewicz J.
Solar Retinopathy. Klin Oczna 100:
235-237, 1998.

18.

De La Paz MA, D’amico DJ. Photic
retinopathy. Principles and Practice of
Ophthalmology (Eds: Albert DM, Jacobiec FA, Robinson NL). Saunders Company Philadelphia-1994. pp 1032-7.

19.

Atmaca LS, Idil A, Can D. Early and late
visual prognosis in solar retinopathy.
Graefes-Arch-Clin-Exp-Ophthalmol 233:
801-4, 1995.

20.

Rosner M, Lam TT, Fu J, Tso MO.
Methylprednisolone ameliorates retinal
photic injury in rats. Arch Ophthalmol
110: 857-861,1992.

401

